Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

New research suggests that weight loss injections, also known as GLP-1 receptor agonists, may have a significant anti-cancer ...

Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a ...

But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...

London: The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity ... both to treat obesity and type 2 diabetes. The WHO's essential medicines list ...

As new figures show how obesity is rising among children and teenagers, doctors debate if weight loss jabs are the answer ...

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

Semaglutide — known by brand names Ozempic and Wegovy — works in the brain to impact satiety. Over the past two years, the popularity of weekly injections for weight loss has soared.